The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, first-in-human study of IB-T101, an OUTLAST CAR-T product for the treatment of CD70-positive clear cell renal carcinoma.
 
Matthias Schroff
Employment - Inceptor Bio
Leadership - Inceptor Bio
Stock and Other Ownership Interests - Inceptor Bio
Patents, Royalties, Other Intellectual Property - Inceptor Bio
 
Bo Liu
No Relationships to Disclose
 
Warren Anderson
Employment - Inceptor Bio
Stock and Other Ownership Interests - Inceptor Bio
Patents, Royalties, Other Intellectual Property - Inceptor Bio
 
Mathew Esquivel
Employment - Inceptor Bio
Stock and Other Ownership Interests - Inceptor Bio
 
Adam Pecoraro
Employment - Inceptor Bio
Stock and Other Ownership Interests - Inceptor Bio
 
Kate Fagan-Solis
Employment - Inceptor Bio
Stock and Other Ownership Interests - Inceptor Bio
 
Yuning Lei
Employment - Grit Biotechnology
 
Jun Cui
Employment - Grit Biotechnology
 
Yarong Liu
Employment - Grit Biotechnology
Leadership - Grit Biotechnology
 
Kevin Carbajal
Employment - Inceptor Bio
Stock and Other Ownership Interests - Inceptor Bio
Patents, Royalties, Other Intellectual Property - Inceptor Bio
 
Maximilian Richter
Employment - Inceptor Bio
Stock and Other Ownership Interests - Inceptor Bio
Patents, Royalties, Other Intellectual Property - Inceptor Bio